
Mornfresh 6.25mg Tablet SR
Marketer
Sansu Life Sciences
Salt Composition
Zolpidem (6.25mg)
Overview Mornfresh 6.25mg Tablet SR
SomniRest 6.25mg Extended-Release Tablets are indicated for the short-term management of sleeplessness. They shorten sleep latency and reduce nocturnal awakenings, promoting sustained sleep. SomniRest 6.25mg Extended-Release Tablets should be administered on an empty stomach, ideally just before bedtime. Consistent daily dosing is recommended to maintain stable drug levels. Always adhere to your physician's prescribed dosage and duration, as this medication can be habit-forming. Abrupt cessation should be avoided without consulting your doctor, as it might exacerbate symptoms. Commonly reported adverse effects include memory impairment, visual or auditory distortions, restlessness, cephalalgia, dizziness, diarrhea, nausea, emesis, and lower back discomfort. Fatigue, abdominal pain, diplopia, and depressive symptoms may also occur, but these are typically transient and self-limiting. Report any persistent or bothersome side effects to your doctor. SomniRest 6.25mg Extended-Release Tablets may induce somnolence and lightheadedness; therefore, avoid driving or activities requiring alertness until the medication's effects are known. Refrain from alcohol consumption as it can potentiate dizziness. Report any unusual mood or behavioral shifts, new or worsening depression, perceptual disturbances, or suicidal ideation to your doctor immediately. Prior to commencing SomniRest 6.25mg Extended-Release Tablets, disclose all other medications to your physician to assess potential drug interactions. Patients with hepatic or renal impairment should consult their doctor before use. Avoid tobacco and alcohol while using this medication. It is contraindicated in pregnancy and lactation; however, consult your doctor if use becomes necessary.
Uses of Mornfresh 6.25mg Tablet SR
Managing Sleep Difficulties
Major Benefits of Mornfresh 6.25mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mornfresh 6.25mg SR tablets on an empty stomach.
Common Side effects of Mornfresh 6.25mg Tablet SR:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Mornfresh 6.25mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 6.25mg Mornfresh SR tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Mornfresh 6.25mg Tablet SR works:
Mornfresh 6.25mg Extended-Release Tablets are classified as non-benzodiazepine sleeping medications. This drug exhibits hypnotic, sedative, and anticonvulsive effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter, to reduce neuronal activity in the brain and facilitate sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Taking Mornfresh 6.25mg sustained-release tablets with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Mornfresh 6.25mg Extended-Release Tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing this medication. Patient consultation with a doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Mornfresh 6.25mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking a Mornfresh 6.25mg sustained-release tablet could reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Mornfresh 6.25mg Tablet SR without requiring a dosage change. Nevertheless, disclosure of any kidney condition to your physician is advised.
LiverCAUTION
Patients with liver impairment should use Mornfresh 6.25mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, Mornfresh 6.25mg Tablet SR is typically initiated at a reduced dosage; it's contraindicated in severe hepatic dysfunction.
What if you forget to take Mornfresh 6.25mg Tablet SR :
Omit any missed Mornfresh 6.25mg Tablet SR dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Mornfresh 6.25mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Imidazopyridine-based compound |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavioral Class | Non-benzodiazepine sleeping medications (Z-drugs) |
